These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 1670067

  • 1. Elderly patients with suppressed serum TSH but normal free thyroid hormone levels usually have mild thyroid overactivity and are at increased risk of developing overt hyperthyroidism.
    Stott DJ, McLellan AR, Finlayson J, Chu P, Alexander WD.
    Q J Med; 1991 Jan; 78(285):77-84. PubMed ID: 1670067
    [Abstract] [Full Text] [Related]

  • 2. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
    Bayer MF, Kriss JP, McDougall IR.
    J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
    [Abstract] [Full Text] [Related]

  • 3. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G, Testa A, Giacomini D, Carrozza C, Maussier ML, Valenza V, D'Errico GF.
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [Abstract] [Full Text] [Related]

  • 4. Hypothyroidism and hyperthyroidism in major depression revisited.
    Fava M, Labbate LA, Abraham ME, Rosenbaum JF.
    J Clin Psychiatry; 1995 May; 56(5):186-92. PubMed ID: 7737957
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment.
    Amato G, Mazziotti G, Sorvillo F, Piscopo M, Lalli E, Biondi B, Iorio S, Molinari A, Giustina A, Carella C.
    Bone; 2004 Sep; 35(3):785-91. PubMed ID: 15336617
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Variable thyrotropin response to thyrotropin-releasing hormone after small decreases in plasma free thyroid hormone concentrations in patients with nonthyroidal diseases.
    Maturlo SJ, Rosenbaum RL, Pan C, Surks MI.
    J Clin Invest; 1980 Sep; 66(3):451-6. PubMed ID: 6772675
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of procollagen III peptide as a marker of tissue hyperthyroidism in long-term treated women with TSH suppressive doses of thyroxine.
    Zulewski H, Siggelkow H, Walden C, Becker W, Hüfner M.
    Exp Clin Endocrinol Diabetes; 1999 Sep; 107(3):190-4. PubMed ID: 10376444
    [Abstract] [Full Text] [Related]

  • 11. Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism.
    Sawin CT, Geller A, Kaplan MM, Bacharach P, Wilson PW, Hershman JM.
    Arch Intern Med; 1991 Jan; 151(1):165-8. PubMed ID: 1985591
    [Abstract] [Full Text] [Related]

  • 12. Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4 mIU/l: a prospective study.
    Rosario PW.
    Clin Endocrinol (Oxf); 2010 May; 72(5):685-8. PubMed ID: 20447066
    [Abstract] [Full Text] [Related]

  • 13. Correlation between thyroxine, triiodothyronine and thyrotropin in geriatric patients with goitre.
    Varl B, Pavlin K.
    Acta Med Austriaca; 1990 May; 17 Suppl 1():71-3. PubMed ID: 2389637
    [Abstract] [Full Text] [Related]

  • 14. TRH testing, T4-thyrotoxicosis and the aging thyroid gland.
    Croxson MS, Wilson TM, Ballantyne GH.
    N Z Med J; 1981 Jun 24; 93(686):417-20. PubMed ID: 6789262
    [Abstract] [Full Text] [Related]

  • 15. [Diagnostic value of blood TSH levels in seriously ill patients].
    Dubuis JM, Vadas L, Burger AG.
    Schweiz Med Wochenschr; 1987 Jul 25; 117(30):1125-9. PubMed ID: 3672065
    [Abstract] [Full Text] [Related]

  • 16. Etiology and outcome of non-estrogen associated hyperthyroxinemia in euthyroid patients at the San Juan City Hospital.
    Alegre M, Meléndez EG, Colón G.
    Bol Asoc Med P R; 1996 Jul 25; 88(1-3):12-5. PubMed ID: 8885441
    [Abstract] [Full Text] [Related]

  • 17. Association between serum free thyroxine concentration and atrial fibrillation.
    Gammage MD, Parle JV, Holder RL, Roberts LM, Hobbs FD, Wilson S, Sheppard MC, Franklyn JA.
    Arch Intern Med; 2007 May 14; 167(9):928-34. PubMed ID: 17502534
    [Abstract] [Full Text] [Related]

  • 18. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ, Utiger RD.
    J Clin Invest; 1973 Sep 14; 52(9):2305-12. PubMed ID: 4199417
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
    Celani MF, Bonati ME, Stucci N.
    Diabetes Res; 1994 Sep 14; 27(1):15-25. PubMed ID: 7648793
    [Abstract] [Full Text] [Related]

  • 20. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W, Spieker K, Weike AI, Giessmann T, Modess C, Dabers T, Kirsch G, Sänger E, Engel G, Hamm AO, Nauck M, Meng W.
    Clin Endocrinol (Oxf); 2004 Jun 14; 60(6):750-7. PubMed ID: 15163340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.